Search hospitals
>
Louisiana
>
Shreveport
Louisiana State University Health Sciences Center Shreveport
Claim this profile
Shreveport, Louisiana 71103
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Lymphoma
312 reported clinical trials
11 medical researchers
Summary
Louisiana State University Health Sciences Center Shreveport is a medical facility located in Shreveport, Louisiana. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Lymphoma and other specialties. Louisiana State University Health Sciences Center Shreveport is involved with conducting 312 clinical trials across 439 conditions. There are 11 research doctors associated with this hospital, such as Gary V. Burton, Poornima Ramadas, Samip Master, and Kavitha Beedupalli.
Area of expertise
Breast Cancer
Louisiana State University Health Sciences Center Shreveport has run 40 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Louisiana State University Health Sciences Center Shreveport has run 38 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Gary V. Burton
LSU Health Sciences Center at Shreveport
2 years of reported clinical research
Poornima Ramadas
LSU Health Sciences Center at Shreveport
6 years of reported clinical research
Samip Master
LSU Health Sciences Center at Shreveport
4 years of reported clinical research
Kavitha Beedupalli
Ochsner LSU Health Monroe Medical Center
11 years of reported clinical research
Clinical Trials running at Louisiana State University Health Sciences Center Shreveport
Breast Cancer
Breast cancer
Multiple Myeloma
Ovarian Cancer
Cancer
Colorectal Cancer
Lung Cancer
Non-Hodgkin's Lymphoma
Heart Failure
Brain Tumor
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Louisiana State University Health Sciences Center Shreveport?
Louisiana State University Health Sciences Center Shreveport is a medical facility located in Shreveport, Louisiana. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Lymphoma and other specialties. Louisiana State University Health Sciences Center Shreveport is involved with conducting 312 clinical trials across 439 conditions. There are 11 research doctors associated with this hospital, such as Gary V. Burton, Poornima Ramadas, Samip Master, and Kavitha Beedupalli.
Where is Louisiana State University Health Sciences Center Shreveport located?
**Louisiana State University Health Sciences Center Shreveport** - **Address:** 1501 Kings Highway, Shreveport, LA 71103 - **Free Patient Parking:** Available at the Gordon H. Schuckers Rehabilitation Pavilion, 1450 Claiborne Ave, Shreveport, LA 71103.
Who should I call to ask about financial aid or insurance network?
**Louisiana State University Health Sciences Center Shreveport - Financial and Insurance Assistance** - For financial assistance, reach out to the Office of Financial Aid at LSUS. - For insurance-related inquiries, contact the Registrar's office at registrar@lsuhs.edu or call 318-675-5207.
What insurance does Louisiana State University Health Sciences Center Shreveport accept?
The Louisiana State University Health Sciences Center Shreveport accepts a wide range of insurance plans, including: - LSU First Health Plan - LSU First Medicare Retiree Plan - Blue Cross Blue Shield Magnolia Local and Local Plus - Blue Cross Blue Shield of LA Magnolia Open Access - Pelican HRA 1000 - Retiree Medicare Advantage plans - Medicare Advantage Plans: LSU First Medicare Retiree Plan (United Healthcare), People's Health, Humana Blue Advantage, and Via Benefits.
What awards or recognition has Louisiana State University Health Sciences Center Shreveport received?
Louisiana State University Health Sciences Center Shreveport (LSUHS) is celebrated for the accomplishments of 14 researchers, highlighting its dedication to medical advancement. LSUHS has partnered with Digital Science to enhance its research program, striving for global recognition in both basic science and clinical research.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.